Cambridge MA | June 2024
Clear Scientific is featured in the June 24, 2024 issue of Eureka: A Dose of Science, a multimedia platform that continually searches for creative ways to talk about science, including breaking news science and the people behind it. The article, titled “A Novel Therapeutic Takes Aim at the Fentanyl and Meth Crisis,” [A Novel Therapeutic Takes Aim at the Fentanyl and Meth Crisis | Eureka blog (criver.com)] describes Clear's efforts to develop an effective antidote to battle this worsening health care crisis.
About Clear Scientific
Clear Scientific is a Cambridge, MA-based clinical stage biopharmaceutical company developing novel therapies for life-threatening and debilitating conditions caused by an excess of harmful substances in the body. CSInc is working closely with our co-founder Prof. George Whitesides at Harvard University, who pioneered the development of modern sequestrant-based therapeutics, and leading physicians at Massachusetts General Hospital.
For more information, visit https://www.clearsci.com.
Comments